Intensity Therapeutics prices $2.35M public offering of common stock and warrants

INTENSITY THERAPEUTICS, INC.

3,133,333 shares and two series of warrants priced at $0.75 per unit; gross proceeds ~$2.35M.
Net proceeds of ~$1.9M after 7% placement agent fee and expenses.
Series B-1 warrants ($0.85 exercise, 5-yr term) and B-2 warrants ($0.85, 18-mo term).
Proceeds for INVINCIBLE-4 patient enrollment, INVINCIBLE-3 treatment, and working capital.
Offering expected to close April 28, 2025; A.G.P. and Brookline Capital Markets as placement agents.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.